+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Intestinal Anti-infective Drugs Market - Global Forecast 2026-2032- Product Image
Intestinal Anti-infective Drugs Market - Global Forecast 2026-2032- Product Image
Sale

Intestinal Anti-infective Drugs Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6148273
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Intestinal Anti-infective Drugs Market is projected to reach USD 181.36 Million in 2026. It is expected to continue growing at a CAGR of 9.27%, reaching USD 308.01 Million by 2032.

Intestinal Anti-infective Drugs: Executive Overview

Intestinal anti-infective drugs are used to manage bacterial, protozoal, and selected parasitic infections affecting the gastrointestinal tract. The field is shaped by infectious-disease burden, diagnostic accuracy, antimicrobial stewardship, treatment guidelines, sanitation conditions, regulatory controls, and access to essential medicines. Clinical practice increasingly distinguishes patients who require targeted therapy from those best managed with hydration, symptom control, and observation.

Shifts Toward Targeted, Stewardship-Aligned Treatment

The landscape is moving toward narrower-spectrum therapy, pathogen-specific diagnosis, and stronger controls on inappropriate antimicrobial use. Multiplex testing, resistance surveillance, updated treatment protocols, and better infection-prevention practices are influencing prescribing decisions. Product differentiation increasingly depends on tolerability, pediatric suitability, dosing convenience, formulation stability, and compatibility with local clinical guidelines rather than on broad empirical use alone.

Artificial Intelligence Strengthens Diagnosis and Antimicrobial Stewardship

Artificial intelligence can support intestinal infection management by identifying patterns in laboratory results, symptoms, travel history, and resistance data. Potential applications include triage support, outbreak detection, treatment-pathway selection, adverse-event monitoring, and forecasting of medicine demand. Its value depends on representative datasets, clinical validation, transparent decision rules, protection of patient information, and continued oversight by qualified clinicians; it should complement rather than replace microbiological testing and medical judgment.

Regional Insights: Uneven Disease Burden and Access Conditions

North America and Europe generally combine stronger diagnostic infrastructure with mature stewardship programs, although resistant infections and access disparities remain important concerns. Latin America continues to face varied sanitation conditions, uneven laboratory capacity, and differences in regulatory access across countries. The Middle East and Africa show substantial variation in healthcare infrastructure, outbreak exposure, supply continuity, and availability of trained personnel. Asia-Pacific spans highly advanced health systems and settings where enteric infections, sanitation gaps, and limited diagnostic access continue to influence treatment decisions. Across all regions, locally relevant guidelines and reliable medicine supply are central to responsible use.

Group Insights: Diverse Policy and Health-System Priorities

ASEAN countries reflect wide differences in health-system capacity, tropical disease exposure, regulation, and antimicrobial stewardship implementation. BRICS members face varied burdens of gastrointestinal infection, resistance surveillance capabilities, and public-sector access conditions. The European Union emphasizes harmonized safety standards, surveillance, and prudent antimicrobial use. G7 systems generally have advanced diagnostics and pharmacovigilance, while still managing resistant pathogens and vulnerable populations. GCC countries benefit from comparatively strong healthcare investment in several settings but must address imported infections, prescribing consistency, and regional workforce needs. NATO members have an additional interest in preparedness for outbreaks affecting military and civilian populations, alongside routine public-health priorities.

Country Insights: Local Guidelines and Delivery Capacity Matter

Australia and Canada emphasize stewardship, surveillance, and access across geographically dispersed populations. Brazil, Mexico, and India must accommodate substantial regional variation in sanitation, healthcare access, and diagnostic availability. China, Japan, and South Korea combine advanced medical capabilities with ongoing attention to resistance, foodborne disease, and aging-population needs. France, Germany, Italy, Spain, and the United Kingdom operate within closely monitored regulatory and stewardship environments, with differences in reimbursement, prescribing pathways, and laboratory practice. Russia presents a large and geographically diverse health system in which supply continuity, surveillance, and guideline implementation are important. Across these countries, pediatric formulations, rural access, diagnostic turnaround, and resistance-informed treatment remain practical priorities.

Actions for Leaders: Build Evidence, Access, and Stewardship Together

Industry leaders should align product development with clearly defined pathogens, patient groups, and treatment settings; generate evidence on safety, effectiveness, resistance, and real-world use; and design formulations suitable for children and resource-constrained environments. Partnerships with laboratories, public-health agencies, hospitals, and antimicrobial-stewardship programs can improve surveillance and appropriate utilization. Supply-chain resilience, quality assurance, transparent educational materials, and responsible engagement with prescribers are essential. Digital and AI-enabled tools should be introduced only with clinical validation, cybersecurity safeguards, bias testing, and measurable impact assessments.

Research Methodology: Evidence-Based Market Interpretation

This executive summary uses the supplied market category as its scope and synthesizes established clinical, public-health, regulatory, and health-system considerations relevant to intestinal anti-infective drugs. The assessment is qualitative and comparative, focusing on treatment practice, stewardship, diagnostics, access, resistance, and regional variation. It does not provide market estimates, market sizing, market shares, forecasts, or company-level analysis. Geographic interpretation is organized around the specified regions, groups, and countries, with conclusions framed as evidence-informed priorities rather than numerical claims.

Conclusion: Responsible Treatment Depends on Precision and Access

The intestinal anti-infective drugs landscape is being reshaped by antimicrobial resistance, improved diagnostics, stewardship requirements, uneven healthcare access, and growing interest in data-supported decision-making. Sustainable progress will depend on matching therapy to confirmed or strongly suspected pathogens, strengthening prevention and surveillance, maintaining dependable supply, and ensuring that innovation improves outcomes without encouraging unnecessary use. Leaders that combine clinical evidence, responsible access strategies, and disciplined implementation will be best positioned to support effective intestinal infection care.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Intestinal Anti-infective Drugs Market, by Drug Class
7.1. Introduction
7.2. Fluoroquinolones
7.3. Macrolides
7.4. Nitroimidazoles
7.5. Tetracyclines
8. Intestinal Anti-infective Drugs Market, by Route Of Administration
8.1. Introduction
8.2. Intravenous
8.2.1. Bolus
8.2.2. Continuous Infusion
8.3. Oral
8.3.1. Extended Release
8.3.2. Immediate Release
8.4. Rectal
8.4.1. Enemas
8.4.2. Suppositories
9. Intestinal Anti-infective Drugs Market, by Distribution Channel
9.1. Introduction
9.2. Online Pharmacy
9.2.1. Direct To Patient
9.2.2. Third-Party Platforms
9.3. Offline
10. Intestinal Anti-infective Drugs Market, by Indication
10.1. Introduction
10.2. Acute Infectious Diarrhea
10.2.1. Bacterial
10.2.2. Parasitic
10.2.2.1. Amoebiasis
10.2.2.2. Cryptosporidiosis
10.2.3. Viral
10.3. Clostridioides Difficile Infection
10.4. Giardiasis
10.5. Traveler’s Diarrhea
11. Intestinal Anti-infective Drugs Market, by Patient Demographic
11.1. Introduction
11.2. Adult
11.3. Geriatric
11.4. Pediatric
12. Intestinal Anti-infective Drugs Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Intestinal Anti-infective Drugs Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Intestinal Anti-infective Drugs Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. AstraZeneca PLC
16.3. Aurobindo Pharma Limited
16.4. Bayer AG
16.5. Bristol-Myers Squibb Company
16.6. Cipla Limited
16.7. Dr. Reddy's Laboratories Ltd.
16.8. Eli Lilly and Company
16.9. Gilead Sciences, Inc.
16.10. GlaxoSmithKline plc
16.11. Johnson & Johnson
16.12. Lupin Limited
16.13. Merck & Co., Inc.
16.14. Mylan N.V.
16.15. Novartis AG
16.16. Pfizer Inc.
16.17. Roche Holding AG
16.18. Sanofi S.A.
16.19. Sun Pharmaceutical Industries Ltd.
16.20. Teva Pharmaceutical Industries Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Intestinal Anti-infective Drugs Market, Years Considered for the Study
FIGURE 2. Global Intestinal Anti-infective Drugs Market, Research Design
FIGURE 3. Global Intestinal Anti-infective Drugs Market, Research Framework
FIGURE 4. Global Intestinal Anti-infective Drugs Market, Data Triangulation
FIGURE 5. Global Intestinal Anti-infective Drugs Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Intestinal Anti-infective Drugs Market Size, by Drug Class, 2025 vs 2032 (%)
FIGURE 7. Global Intestinal Anti-infective Drugs Market Size, by Drug Class, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 9. Global Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 11. Global Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Intestinal Anti-infective Drugs Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 13. Global Intestinal Anti-infective Drugs Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2025 vs 2032 (%)
FIGURE 15. Global Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Intestinal Anti-infective Drugs Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Intestinal Anti-infective Drugs Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Intestinal Anti-infective Drugs Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Intestinal Anti-infective Drugs Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Intestinal Anti-infective Drugs Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Intestinal Anti-infective Drugs Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Intestinal Anti-infective Drugs Market Segmentation & Coverage
TABLE 2. Global Intestinal Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 3. Global Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 4. Global Fluoroquinolones Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Fluoroquinolones Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Fluoroquinolones Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Macrolides Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Macrolides Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Macrolides Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Nitroimidazoles Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Nitroimidazoles Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Nitroimidazoles Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Tetracyclines Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Tetracyclines Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Tetracyclines Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 17. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Bolus Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Bolus Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Bolus Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Continuous Infusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Continuous Infusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Continuous Infusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Extended Release Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Extended Release Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Extended Release Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Immediate Release Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Immediate Release Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Immediate Release Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Rectal Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Rectal Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Rectal Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Enemas Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Enemas Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Enemas Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Suppositories Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Suppositories Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Suppositories Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 45. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Direct To Patient Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Direct To Patient Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Direct To Patient Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Third-Party Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Third-Party Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Third-Party Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 58. Global Acute Infectious Diarrhea Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Acute Infectious Diarrhea Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Acute Infectious Diarrhea Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Bacterial Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Bacterial Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Bacterial Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Parasitic Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Parasitic Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Parasitic Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Amoebiasis Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Amoebiasis Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Amoebiasis Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Cryptosporidiosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Cryptosporidiosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Cryptosporidiosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Viral Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Viral Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Viral Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Clostridioides Difficile Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Clostridioides Difficile Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Clostridioides Difficile Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Giardiasis Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Giardiasis Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Giardiasis Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Traveler’s Diarrhea Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Traveler’s Diarrhea Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Traveler’s Diarrhea Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 86. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Geriatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Geriatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Geriatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Intestinal Anti-infective Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Intestinal Anti-infective Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Intestinal Anti-infective Drugs Market Size, by Rectal, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Intestinal Anti-infective Drugs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Intestinal Anti-infective Drugs Market Size, by Acute Infectious Diarrhea, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Intestinal Anti-infective Drugs Market Size, by Parasitic, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 108. North America Intestinal Anti-infective Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. North America Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 110. North America Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 111. North America Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 112. North America Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 113. North America Intestinal Anti-infective Drugs Market Size, by Rectal, 2017-2032 (USD Million)
TABLE 114. North America Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 115. North America Intestinal Anti-infective Drugs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 116. North America Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 117. North America Intestinal Anti-infective Drugs Market Size, by Acute Infectious Diarrhea, 2017-2032 (USD Million)
TABLE 118. North America Intestinal Anti-infective Drugs Market Size, by Parasitic, 2017-2032 (USD Million)
TABLE 119. North America Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 120. Latin America Intestinal Anti-infective Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Latin America Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 122. Latin America Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 123. Latin America Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 124. Latin America Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 125. Latin America Intestinal Anti-infective Drugs Market Size, by Rectal, 2017-2032 (USD Million)
TABLE 126. Latin America Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 127. Latin America Intestinal Anti-infective Drugs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 128. Latin America Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 129. Latin America Intestinal Anti-infective Drugs Market Size, by Acute Infectious Diarrhea, 2017-2032 (USD Million)
TABLE 130. Latin America Intestinal Anti-infective Drugs Market Size, by Parasitic, 2017-2032 (USD Million)
TABLE 131. Latin America Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 132. Europe Intestinal Anti-infective Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Europe Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 134. Europe Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 135. Europe Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 136. Europe Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 137. Europe Intestinal Anti-infective Drugs Market Size, by Rectal, 2017-2032 (USD Million)
TABLE 138. Europe Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 139. Europe Intestinal Anti-infective Drugs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 140. Europe Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 141. Europe Intestinal Anti-infective Drugs Market Size, by Acute Infectious Diarrhea, 2017-2032 (USD Million)
TABLE 142. Europe Intestinal Anti-infective Drugs Market Size, by Parasitic, 2017-2032 (USD Million)
TABLE 143. Europe Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 144. Middle East Intestinal Anti-infective Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Middle East Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 146. Middle East Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 147. Middle East Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 148. Middle East Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 149. Middle East Intestinal Anti-infective Drugs Market Size, by Rectal, 2017-2032 (USD Million)
TABLE 150. Middle East Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 151. Middle East Intestinal Anti-infective Drugs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 152. Middle East Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 153. Middle East Intestinal Anti-infective Drugs Market Size, by Acute Infectious Diarrhea, 2017-2032 (USD Million)
TABLE 154. Middle East Intestinal Anti-infective Drugs Market Size, by Parasitic, 2017-2032 (USD Million)
TABLE 155. Middle East Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 156. Africa Intestinal Anti-infective Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Africa Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 158. Africa Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 159. Africa Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 160. Africa Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 161. Africa Intestinal Anti-infective Drugs Market Size, by Rectal, 2017-2032 (USD Million)
TABLE 162. Africa Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 163. Africa Intestinal Anti-infective Drugs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 164. Africa Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 165. Africa Intestinal Anti-infective Drugs Market Size, by Acute Infectious Diarrhea, 2017-2032 (USD Million)
TABLE 166. Africa Intestinal Anti-infective Drugs Market Size, by Parasitic, 2017-2032 (USD Million)
TABLE 167. Africa Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 168. Global Intestinal Anti-infective Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. ASEAN Intestinal Anti-infective Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. ASEAN Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 171. ASEAN Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 172. ASEAN Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 173. ASEAN Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 174. ASEAN Intestinal Anti-infective Drugs Market Size, by Rectal, 2017-2032 (USD Million)
TABLE 175. ASEAN Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 176. ASEAN Intestinal Anti-infective Drugs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 177. ASEAN Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 178. ASEAN Intestinal Anti-infective Drugs Market Size, by Acute Infectious Diarrhea, 2017-2032 (USD Million)
TABLE 179. ASEAN Intestinal Anti-infective Drugs Market Size, by Parasitic, 2017-2032 (USD Million)
TABLE 180. ASEAN Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 181. GCC Intestinal Anti-infective Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. GCC Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 183. GCC Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 184. GCC Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 185. GCC Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 186. GCC Intestinal Anti-infective Drugs Market Size, by Rectal, 2017-2032 (USD Million)
TABLE 187. GCC Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. GCC Intestinal Anti-infective Drugs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 189. GCC Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 190. GCC Intestinal Anti-infective Drugs Market Size, by Acute Infectious Diarrhea, 2017-2032 (USD Million)
TABLE 191. GCC Intestinal Anti-infective Drugs Market Size, by Parasitic, 2017-2032 (USD Million)
TABLE 192. GCC Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 193. European Union Intestinal Anti-infective Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 194. European Union Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 195. European Union Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 196. European Union Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 197. European Union Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 198. European Union Intestinal Anti-infective Drugs Market Size, by Rectal, 2017-2032 (USD Million)
TABLE 199. European Union Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 200. European Union Intestinal Anti-infective Drugs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 201. European Union Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 202. European Union Intestinal Anti-infective Drugs Market Size, by Acute Infectious Diarrhea, 2017-2032 (USD Million)
TABLE 203. European Union Intestinal Anti-infective Drugs Market Size, by Parasitic, 2017-2032 (USD Million)
TABLE 204. European Union Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 205. BRICS Intestinal Anti-infective Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 206. BRICS Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 207. BRICS Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 208. BRICS Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 209. BRICS Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 210. BRICS Intestinal Anti-infective Drugs Market Size, by Rectal, 2017-2032 (USD Million)
TABLE 211. BRICS Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 212. BRICS Intestinal Anti-infective Drugs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 213. BRICS Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 214. BRICS Intestinal Anti-infective Drugs Market Size, by Acute Infectious Diarrhea, 2017-2032 (USD Million)
TABLE 215. BRICS Intestinal Anti-infective Drugs Market Size, by Parasitic, 2017-2032 (USD Million)
TABLE 216. BRICS Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 217. G7 Intestinal Anti-infective Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 218. G7 Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 219. G7 Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 220. G7 Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 221. G7 Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 222. G7 Intestinal Anti-infective Drugs Market Size, by Rectal, 2017-2032 (USD Million)
TABLE 223. G7 Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 224. G7 Intestinal Anti-infective Drugs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 225. G7 Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 226. G7 Intestinal Anti-infective Drugs Market Size, by Acute Infectious Diarrhea, 2017-2032 (USD Million)
TABLE 227. G7 Intestinal Anti-infective Drugs Market Size, by Parasitic, 2017-2032 (USD Million)
TABLE 228. G7 Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 229. NATO Intestinal Anti-infective Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 230. NATO Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 231. NATO Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 232. NATO Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 233. NATO Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 234. NATO Intestinal Anti-infective Drugs Market Size, by Rectal, 2017-2032 (USD Million)
TABLE 235. NATO Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 236. NATO Intestinal Anti-infective Drugs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 237. NATO Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 238. NATO Intestinal Anti-infective Drugs Market Size, by Acute Infectious Diarrhea, 2017-2032 (USD Million)
TABLE 239. NATO Intestinal Anti-infective Drugs Market Size, by Parasitic, 2017-2032 (USD Million)
TABLE 240. NATO Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 241. Global Intestinal Anti-infective Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 242. United States Intestinal Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 243. United States Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 244. United States Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 245. United States Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 246. United States Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 247. United States Intestinal Anti-infective Drugs Market Size, by Rectal, 2017-2032 (USD Million)
TABLE 248. United States Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 249. United States Intestinal Anti-infective Drugs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 250. United States Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 251. United States Intestinal Anti-infective Drugs Market Size, by Acute Infectious Diarrhea, 2017-2032 (USD Million)
TABLE 252. United States Intestinal Anti-infective Drugs Market Size, by Parasitic, 2017-2032 (USD Million)
TABLE 253. United States Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 254. Canada Intestinal Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 255. Canada Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 256. Canada Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 257. Canada Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 258. Canada Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 259. Canada Intestinal Anti-infective Drugs Market Size, by Rectal, 2017-2032 (USD Million)
TABLE 260. Canada Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 261. Canada Intestinal Anti-infective Drugs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 262. Canada Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 263. Canada Intestinal Anti-infective Drugs Market Size, by Acute Infectious Diarrhea, 2017-2032 (USD Million)
TABLE 264. Canada Intestinal Anti-infective Drugs Market Size, by Parasitic, 2017-2032 (USD Million)
TABLE 265. Canada Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 266. Mexico Intestinal Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 267. Mexico Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 268. Mexico Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 269. Mexico Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 270. Mexico Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 271. Mexico Intestinal Anti-infective Drugs Market Size, by Rectal, 2017-2032 (USD Million)
TABLE 272. Mexico Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 273. Mexico Intestinal Anti-infective Drugs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 274. Mexico Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 275. Mexico Intestinal Anti-infective Drugs Market Size, by Acute Infectious Diarrhea, 2017-2032 (USD Million)
TABLE 276. Mexico Intestinal Anti-infective Drugs Market Size, by Parasitic, 2017-2032 (USD Million)
TABLE 277. Mexico Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 278. Brazil Intestinal Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 279. Brazil Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 280. Brazil Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 281. Brazil Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 282. Brazil Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 283. Brazil Intestinal Anti-infective Drugs Market Size, by Rectal, 2017-2032 (USD Million)
TABLE 284. Brazil Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 285. Brazil Intestinal Anti-infective Drugs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 286. Brazil Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 287. Brazil Intestinal Anti-infective Drugs Market Size, by Acute Infectious Diarrhea, 2017-2032 (USD Million)
TABLE 288. Brazil Intestinal Anti-infective Drugs Market Size, by Parasitic, 2017-2032 (USD Million)
TABLE 289. Brazil Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 290. United Kingdom Intestinal Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 291. United Kingdom Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 292. United Kingdom Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 293. United Kingdom Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 294. United Kingdom Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 295. United Kingdom Intestinal Anti-infective Drugs Market Size, by Rectal, 2017-2032 (USD Million)
TABLE 296. United Kingdom Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 297. United Kingdom Intestinal Anti-infective Drugs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 298. United Kingdom Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 299. United Kingdom Intestinal Anti-infective Drugs Market Size, by Acute Infectious Diarrhea, 2017-2032 (USD Million)
TABLE 300. United Kingdom Intestinal Anti-infective Drugs Market Size, by Parasitic, 2017-2032 (USD Million)
TABLE 301. United Kingdom Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 302. Germany Intestinal Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 303. Germany Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 304. Germany Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 305. Germany Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 306. Germany Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 307. Germany Intestinal Anti-infective Drugs Market Size, by Rectal, 2017-2032 (USD Million)
TABLE 308. Germany Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 309. Germany Intestinal Anti-infective Drugs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 310. Germany Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 311. Germany Intestinal Anti-infective Drugs Market Size, by Acute Infectious Diarrhea, 2017-2032 (USD Million)
TABLE 312. Germany Intestinal Anti-infective Drugs Market Size, by Parasitic, 2017-2032 (USD Million)
TABLE 313. Germany Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 314. France Intestinal Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 315. France Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 316. France Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 317. France Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 318. France Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 319. France Intestinal Anti-infective Drugs Market Size, by Rectal, 2017-2032 (USD Million)
TABLE 320. France Intestinal Anti-infective Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 321. France Intestinal Anti-infective Drugs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 322. France Intestinal Anti-infective Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 323. France Intestinal Anti-infective Drugs Market Size, by Acute Infectious Diarrhea, 2017-2032 (USD Million)
TABLE 324. France Intestinal Anti-infective Drugs Market Size, by Parasitic, 2017-2032 (USD Million)
TABLE 325. France Intestinal Anti-infective Drugs Market Size, by Patient Demographic, 2017-2032 (USD Million)
TABLE 326. Russia Intestinal Anti-infective Drugs Market Size, 2017-2032 (USD Million)
TABLE 327. Russia Intestinal Anti-infective Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 328. Russia Intestinal Anti-infective Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 329. Russia Intestinal Anti-infective Drugs Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 330. Russia Intestinal Anti-infective Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 331. Russia Intestinal Anti-infective Drugs Market Size, by Rect

Companies Mentioned

  • Abbott Laboratories
  • AstraZeneca PLC
  • Aurobindo Pharma Limited
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

Related Topics

Related Reports

Pets Anti-infective Drugs Market - Global Forecast 2026-2032 - Product Image

Pets Anti-infective Drugs Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Anti-Infective Agents for Pets Market - Global Forecast 2026-2032 - Product Image

Anti-Infective Agents for Pets Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Anti-Infective Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Anti-Infective Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Anti-infectives Market Report by Type, Route of Administration, Distribution Channel, and Region 2026-2034 - Product Image

Anti-infectives Market Report by Type, Route of Administration, Distribution Channel, and Region 2026-2034

  • Report
  • 140 Pages
  • Global
From
Anti-Infective Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Anti-Infective Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.